OPK Signs with NBA for COVID-19 Testing!

It was just announced that NIA's #1 COVID-19 testing stock suggestion OPKO Health (OPK) will provide COVID-19 testing for the National Basketball Association's (NBA) players and referees, as well as team and league staff participating in the NBA's July 30th season restart in Orlando! Under the agreement with the NBA, OPK's BioReference Labs will provide COVID-19 PCR diagnostics, rapid diagnostics and antibody testing. The NBA and OPK collaborated on testing protocols to provide the safest possible environment to restart the 2019-20 NBA season, going to extraordinary lengths to understand both the threats of the virus and the best means to control its spread.

OPK is up by $0.15 or 3.73% this morning to $4.17 per share! OPK has gained by 100.48% since NIA's April 23rd suggestion at $2.08 per share!

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. This message is meant for informational and educational purposes only and does not provide investment advice.